Search Results For ''

  • A look at upcoming bank reporting

    Last week we saw an earnings report from Bank of Queensland, the first of the domestic banks to report earnings in the October/November period. The report was largely in-line with analysts’ expectations, but the stock fell on the day and has continued lower since then. Perhaps the market was optimistic that results would surprise toRead More
    Public
  • The long road ahead for Seven West Media

    Emerald Financial Rating: Medium-term Sell Price at time of publication: $0.42 The Australian media ranks have once again had their feathers rustled earlier in the year following the resignation of Seven West Media CEO Tim Worner just five days before he had been due to deliver the Groups FY19 financial results. With the timing ofRead More
    Public
  • Australia’s green whistle pain relief winning over Europeans

    Carried and administered by Australian paramedics for decades, the green whistle pain reliever has been on the Australian market for years but clinical trials in Europe have now revealed Penthrox® to be a superior pain relief product than traditional treatments of morphine (IV), paracetamol, ketoprofen and NSAIDS.  Marketed as Penthrox® with the key ingredient of

    Read More
    Public
  • Investing Through Economic Uncertainty – How The Healthcare Sector Has Flourished

    Typically during a recession, consumers reduce their spending. But people can’t stop getting sick, becoming injured, or requiring health care products and services, just because there is a downshift in the economy. So what happens to the healthcare sector when there is a recession? During the Global Financial Crisis between 2007-2009, the ASX 200 recorded

    Read More
    Public
  • Noxopharm achieves significant pain relief for late-stage prostate cancer patients

    Prostate cancer patients could soon be in for potentially good news after clinical stage-drug development company, Noxopharm (ASX: NOX) reported interim data indicating effective anti-cancer responses from patients receiving treatment for late-stage prostate cancer.  To date, the data from the study (DARRT-1) found that 80% of patients showed no further progression in their disease after

    Read More
    Public
  • WineDepot signs foundation client, Australia’s largest family-owned winery

    Tech newcomer Digital Wine Ventures (ASX: DW8) has hit the ground running with the signing of Casella Family Brands, Australia largest family-owned winery, as a foundation client for their one-stop-shop WineDepot platform.  Launched in September 2019, WineDepot is a B2B cloud-based platform which aims to connect wine producers, distributors, importers and retailers enabling producers a

    Read More
    Public